EXOZYMES INC. financial data

Symbol
EXOZ on Nasdaq
Location
Monrovia, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 638% %
Debt-to-equity 31% %
Return On Equity -105% % -138%
Return On Assets -80% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8,387,250 shares 34%
Common Stock, Shares, Outstanding 8,387,250 shares 34%
Common Stock, Value, Issued $8 USD 33%
Weighted Average Number of Shares Outstanding, Basic 8,387,250 shares 34%
Weighted Average Number of Shares Outstanding, Diluted 8,387,250 shares 34%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $3,225,071 USD 68%
General and Administrative Expense $5,779,227 USD 47%
Operating Income (Loss) $9,004,298 USD -56%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $8,341,816 USD -38%
Net Income (Loss) Attributable to Parent $8,339,672 USD -63%
Earnings Per Share, Basic -1 USD/shares 0%
Earnings Per Share, Diluted -1 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,098,687 USD 2080%
Assets, Current $5,606,050 USD 294%
Property, Plant and Equipment, Net $763,012 USD 3.2%
Operating Lease, Right-of-Use Asset $1,124,925 USD -20%
Assets $7,719,049 USD 117%
Accounts Payable, Current $904,353 USD -0.47%
Liabilities, Current $1,238,362 USD -79%
Operating Lease, Liability, Noncurrent $926,587 USD -24%
Liabilities $2,344,627 USD -67%
Retained Earnings (Accumulated Deficit) $18,449,656 USD -82%
Stockholders' Equity Attributable to Parent $5,374,422 USD
Liabilities and Equity $7,719,049 USD 117%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,133,533 USD -503%
Net Cash Provided by (Used in) Financing Activities $43,254 USD 53%
Net Cash Provided by (Used in) Investing Activities $31,046 USD 78%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 8,387,250 shares 34%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,207,833 USD -2656%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,098,687 USD 2080%
Deferred Tax Assets, Valuation Allowance $3,065,959 USD 59%
Operating Lease, Liability $1,200,888 USD -17%
Depreciation $70,503 USD 12%
Payments to Acquire Property, Plant, and Equipment $31,046 USD -79%
Lessee, Operating Lease, Liability, to be Paid $1,386,765 USD -20%
Property, Plant and Equipment, Gross $1,706,075 USD 22%
Operating Lease, Liability, Current $274,301 USD 23%
Lessee, Operating Lease, Liability, to be Paid, Year Two $368,250 USD 2.7%
Lessee, Operating Lease, Liability, to be Paid, Year One $358,428 USD 2.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $185,877 USD -35%
Lessee, Operating Lease, Liability, to be Paid, Year Three $378,576 USD 2.8%
Deferred Tax Assets, Operating Loss Carryforwards $1,306,652 USD 157%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $378,576 USD
Operating Lease, Payments $86,319 USD
Additional Paid in Capital $23,824,070 USD 266%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $481,750 USD -11%
Interest Expense $44,647 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%